For the quarter ending 2025-09-30, GNLX had -$1,854K decrease in cash & cash equivalents over the period. -$7,092K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -7,950 | -14,948 |
| Depreciation expense | 62 | 122 |
| Net amortization of premiums and discounts on short-term investments | 31 | 157 |
| Right-of-use asset | 82 | 160 |
| Stock compensation | 1,623 | 2,713 |
| Fair value of restricted stock units | 290 | 288 |
| Cost of stock option modifications and repricing | -725 | -13 |
| Prepaid expenses and other assets | -577 | 590 |
| Accounts payable and accrued expenses | -2,040 | 453 |
| Accrued payroll and payroll taxes | 170 | -387 |
| Lease liability | -83 | -161 |
| Net cash used in operating activities | -6,575 | -12,494 |
| Purchases of property and equipment | 517 | 145 |
| Purchase of investments | 5,262 | 12,999 |
| Proceeds from maturities of investments | 10,500 | 14,000 |
| Net cash provided by (used in) investing activities | 4,721 | 856 |
| Proceeds from the exercise of stock options | - | 14 |
| Proceeds from common stock issued for company equity award | 0 | 52 |
| Proceeds from the exercise of stock options | 14 | 0 |
| Proceeds from common stock issued | 0 | 9,553 |
| Net cash provided by financing activities | 0 | 9,619 |
| Net decrease in cash, cash equivalents and restricted cash | -1,854 | -2,019 |
| Cash and cash equivalents at beginning of period | 8,565 | - |
| Cash and cash equivalents at end of period | 4,692 | - |
GENELUX Corp (GNLX)
GENELUX Corp (GNLX)